Thoughtful science, published in full.
Qvin runs studies on menstrual blood in the United States, the United Kingdom and Denmark, on its own and with partners. Every study is ethics approved, and we publish what we find, in full and in the open.
Research women can trust.
Menstrual health has waited a long time for good evidence. We hold our own studies to the standard we would want for ourselves.
- 01
Every result, published
We write up and publish what our studies find, in full, whether the result is what we hoped for or not.
- 02
Registered up front
Clinical trials such as EQUIP are registered publicly before they start, with their goals, so the results can be held against the plan.
- 03
Ethics first
An independent review board approves every study, and every participant gives informed consent before taking part.
- 04
Careful with data
Personal details are kept apart from samples and health data, and used only as each participant agreed.
Can the Q-Pad find cervical precancer?
Cervical cancer is one of the most preventable cancers, yet many women skip screening because it means a clinic visit and a speculum exam. EQUIP tests whether high-risk HPV testing on a Q-Pad, collected at home during a period, can find precancer as well as a sample taken in the clinic.
- Adults aged 25 and over, referred for colposcopy after an abnormal screening result
- Each collects with the Q-Pad at home and also has standard clinician sampling and colposcopy
- The goal: show how well the Q-Pad finds precancer (CIN2+), compared with clinician sampling and biopsy, and how easy and acceptable it is to use
- 450
- Participants planned
- Multicenter
- Clinical sites across the United States
- Dec 2025
- Recruiting since
A prospective, multicenter, paired-sample diagnostic study. The Q-Pad is not a cleared HPV test today; EQUIP is how we find out.
Help solve women’s health.
Studies need people who menstruate, of every age, background and health history. Taking part is how the science moves.
Done at home
Collect with the Q-Pad during your period and mail it back. No clinic visits.
Reviewed by an ethics board
Every study is approved by an independent review board, and you sign consent before you start.
Always compensated
Participants are paid for their time in every study.
- USUnited States
- UKUnited Kingdom
- DKDenmark
Run your study from one platform.
Recruitment, consent, home collection, the lab and the biobank, in one system that is already running studies in three countries. Your team focuses on the science; the logistics are handled.
A study site, built for your study
Each study gets its own page on research.qvin.com with consent, screening questions, accounts and follow-up, set up to your protocol.
Recruitment that reaches people
Participants sign up from home, anywhere in the country, with automatic reminders for anyone who starts and does not finish.
eConsent and eligibility
Ethics-approved consent comes first, then screening. Your team reviews each consent and approves who takes part.
Kits to the door, samples back
Q-Pad Kits ship tracked to every participant and come back by ordinary mail, routed to the lab that runs your panel.
Every kit, live
The Study Dashboard shows where every participant and every kit is, from consent to result.
Samples you can come back to
Consented samples can be biobanked at −80 °C with full traceability, for the questions you have not asked yet.
From first call to first sample
Scope the study
Your question, population and measures. We confirm what the Q-Pad can support.
We set it up
Study site, consent, panel and kits, under your protocol and ethics approval.
Participants join
They sign up on the study site and in the Qvin app, and sign eConsent.
You approve
Review each consent in the Study Dashboard and approve who takes part.
Kits out, samples back
Collection at home, mailed to the lab that runs your panel.